At a glance
ClinicalIndex Comparison RecordN/ACompleted· 63 enrolled
Drug / intervention
combination of Cyberknife with S-1other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Stereotactic Body Radiation Therapy With Sequential S-1 for Patients With Locally Advanced Pancreatic Cancer and Poor Medical Conditions --a Phase II Clinical Trial
In Brief
A clinical study evaluating combination of Cyberknife with S-1 for Pancreatic Cancer. Completed, enrolled 63 participants across 1 site.
Detailed Summary
The safety and efficacy of combination of SBRT with sequential S-1 in treating patients with locally advanced pancreatic cancer and poor medical conditions will be evaluated.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Cancer
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartFeb 2016
First PostedMar 2016
Primary CompletionMay 2020
TodayJul 2026
First PostedMar 9, 2016
Enrollment StartFeb 1, 2016
Primary CompletionMay 1, 2020
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 10.3 years ago
Interventions
combination of Cyberknife with S-1other
Radiation therapy combined with chemotherapy